Antineoplastic Agents Associated With Thyroid Dysfunction episode artwork

EPISODE · Oct 18, 2011 · 9 MIN

Antineoplastic Agents Associated With Thyroid Dysfunction

from The JNCI Podcast · host Oxford University Press

Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction.

Episode metadata supplied by the publisher feed · Published Oct 18, 2011

Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction.

PodParley-generated summary based on available episode metadata and transcript content.

NOW PLAYING

Antineoplastic Agents Associated With Thyroid Dysfunction

0:00 9:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The JNCI Podcast?

This episode is 9 minutes long.

When was this The JNCI Podcast episode published?

This episode was published on October 18, 2011.

What is this episode about?

Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction.

Can I download this The JNCI Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!